Search results
Results from the WOW.Com Content Network
The False Claims Act of 1863 (FCA) [1] is an American federal law that imposes liability on persons and companies (typically federal contractors) ...
Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. ___ (2016), was a United States Supreme Court case in which the Court held that "the implied false certification theory can be a basis for False Claims Act liability when a defendant submitting a claim makes specific representations about the goods or services provided, but fails to disclose noncompliance with material ...
The SEC order said that in 2019 UPS determined that its freight division was likely to sell for no more than about $650 million. UPS to pay $45M to US settle charges that it improperly valued its ...
False Claims Act/FDCA 2012 4 4 (tie) Depakote: Abbott Laboratories [8] $1,500,000,000 $800 million civil ($1.5 billion with criminal component) Off-label promotion False Claims Act/FDCA 2009 5 4 (tie) Zyprexa: Eli Lilly [9] $1,450,000,000 $800 million civil ($1.45 billion with criminal component) Off-label promotion False Claims Act/FDCA 2008 10 5
The False Claims Act lets whistleblowers sue on behalf of the federal government, and share in recoveries. Valisure first sued GSK on behalf of the United States and more than two dozen states in ...
During the Civil War, concern over corruption in the Union’s procurement of war supplies moved Congress to pass the False Claims Act, which allowed citizens to bring what was called a qui tam action—a Latin phrase that loosely translates to “he who brings the action for the king as well as himself.”
The UPS website noted that she should expect a resolution to her claim within eight to 10 days. But months later, her son was still without a laptop, and she hadn’t received compensation for the ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...